| Literature DB >> 31183991 |
Andrew G Raub1,2, Sunhee Hwang1, Naoki Horikoshi3,4,5, Anna D Cunningham1,6, Simin Rahighi4,5,7, Soichi Wakatsuki4,5, Daria Mochly-Rosen1.
Abstract
We recently identified AG1, a small-molecule activator that functions by promoting oligomerization of glucose-6-phosphate dehydrogenase (G6PD) to the catalytically competent forms. Biochemical experiments indicate that the activation of G6PD by the original hit molecule (AG1) is noncovalent and that one C2 -symmetric region of the G6PD homodimer is important for ligand function. Consequently, the disulfide in AG1 is not required for activation of G6PD, and a number of analogues were prepared without this reactive moiety. Our study supports a mechanism of action whereby AG1 bridges the dimer interface at the structural nicotinamide adenine dinucleotide phosphate (NADP+ ) binding sites of two interacting G6PD monomers. Small molecules that promote G6PD oligomerization have the potential to provide a first-in-class treatment for G6PD deficiency. This general strategy could be applied to other enzyme deficiencies in which control of oligomerization can enhance enzymatic activity and/or stability.Entities:
Keywords: bivalent ligands; enzyme catalysis; glucose-6-phosphate dehydrogenase; protein-protein interactions; small-molecule activators
Mesh:
Substances:
Year: 2019 PMID: 31183991 PMCID: PMC6701841 DOI: 10.1002/cmdc.201900341
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466